Zhaomin Tang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Metal Organic Framework

Multidrug Resistant

Acinetobacter Baumannii

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Zhaomin Tang, Shuting Jiang, Wanlan Tang, Qian He, Huangzhao Wei, Chengyu Jin, Shuai Wang, Hui Zhang
H 2 O 2 Self-Supplying and GSH-Depleting Nanocatalyst for Copper Metabolism-Based Synergistic Chemodynamic Therapy and Chemotherapy. Molecular pharmaceutics 20 (3) (2023)
Zhaomin Tang, Shuting Jiang, Wanlan Tang, Qian He, Huangzhao Wei, Chengyu Jin, Shuai Wang, Hui Zhang
H 2 O 2 Self-Supplying and GSH-Depleting Nanocatalyst for Copper Metabolism-Based Synergistic Chemodynamic Therapy and Chemotherapy. Molecular pharmaceutics 20 (3) (2023)
Zhaomin Tang, Shuting Jiang, Wanlan Tang, Qian He, Huangzhao Wei, Chengyu Jin, Shuai Wang, Hui Zhang
H 2 O 2 Self-Supplying and GSH-Depleting Nanocatalyst for Copper Metabolism-Based Synergistic Chemodynamic Therapy and Chemotherapy. Molecular pharmaceutics 20 (3) (2023)
Zhaomin Tang, Shuting Jiang, Wanlan Tang, Qian He, Huangzhao Wei, Chengyu Jin, Shuai Wang, Hui Zhang
H 2 O 2 Self-Supplying and GSH-Depleting Nanocatalyst for Copper Metabolism-Based Synergistic Chemodynamic Therapy and Chemotherapy. Molecular pharmaceutics (2023)
Zhaomin Tang, Shuting Jiang, Wanlan Tang, Qian He, Huangzhao Wei, Chengyu Jin, Shuai Wang, Hui Zhang
Correction to "H 2 O 2 Self-Supplying and GSH-Depleting Nanocatalyst for Copper Metabolism-Based Synergistic Chemodynamic Therapy and Chemotherapy". Molecular pharmaceutics (2023)
Zhaomin Tang, Weijun Tian, Hongyu Long, Shuting Jiang, Jianqing Zhao, Jianren Zhou, Qian He, Xia Luo
Subcellular-Targeted Near-Infrared-Responsive Nanomedicine with Synergistic Chemo-photothermal Therapy against Multidrug Resistant Cancer. Molecular pharmaceutics 19 (12) (2022)